Keywords: Shionogi, Europe development subsidiary, Financial results nine months to Dec 31, 2011
Shionogi sets up new EU unit; posts 37% profit hike
Article | 31 January 2012
Japanese drug major Shionogi (TYO: 4507) yesterday revealed that it has decided to establish its 100% owned subsidiary, styled Shionogi Limited, in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
